Hemoglobin A2 (HB A2, in Visit Clinic

Hb A (hemoglobin A) is the predominant adult hemoglobin made of two alpha and two beta chains (α2β2), comprising about 95–98% of adult hemoglobin. HbA2 is a minor adult form (α2δ2), normally about 1.5–3.5% of total hemoglobin. Elevated HbA2 is an important diagnostic marker for beta‑thalassemia trait.

An elevated HbA2 (typically >3.5%) most commonly indicates beta‑thalassemia trait (a carrier state for beta‑thalassemia). It can also occur with other thalassemia or hemoglobin disorders or rarely from lab interference. High HbA2 alone isn’t definitive; clinicians correlate it with CBC, red cell indices and family history, and may recommend genetic testing or hematology referral because carriers can pass affected genes to children.

Low hemoglobin A2 (below ~2.5%) is uncommon and often reflects iron deficiency, recent transfusion, or rare delta‑chain defects (delta‑thalassemia). It can mask or complicate diagnosis of beta‑thalassemia trait. By itself it usually causes no specific symptoms, but prompts iron studies and further hemoglobin/genetic testing to identify the underlying cause and guide management.

Iron deficiency commonly lowers hemoglobin A2 (HbA2) concentrations, which can mask or produce falsely normal/borderline results when screening for beta‑thalassemia trait. After iron stores are repleted, HbA2 often rises to its true level. Therefore, correct iron deficiency before interpreting HbA2 and consider repeat testing following iron therapy.

Treatment depends on the cause. Elevated HbA2 usually indicates beta‑thalassaemia trait — no specific therapy is needed beyond genetic counselling, monitoring and folic acid; avoid unnecessary iron if iron studies are normal. Severe thalassaemia requires regular transfusions, iron chelation and may need bone‑marrow transplant. Low HbA2 suggests iron deficiency or other haemoglobinopathies — treat underlying iron deficiency and refer for specialist testing.

Normal HbA2 is about 2–3.5%. In beta‑thalassemia trait (heterozygous) HbA2 is typically elevated above 3.5%, commonly 4–8%. In beta‑thalassemia major HbA2 can be elevated but interpretation depends on clinical/genetic context and transfusion history. HbA2 is usually normal in alpha‑thalassemia. Iron deficiency or recent transfusion can mask or alter HbA2 results.